Kirby Wallace

Kirby Wallace currently serves as the Head of Business Development at Kamau Therapeutics, a position held since July 2023. Prior to this role, Kirby worked as Scientist II at Graphite Bio from May 2021 to May 2023, and as a Scientist at Mammoth Biosciences from July 2020 to April 2021. Kirby's academic journey culminated in a Ph.D. in Biomedical Research - Cancer and Developmental Biology from The University of Tennessee Health Science Center, where significant research contributed to new therapeutic options for high-risk pediatric cancer. Additional experience includes a consulting role at The University of Tennessee Health Science Center, where a competitive analysis was performed, and several positions including a research assistant at EGEN Inc. and an intern at HudsonAlpha Institute for Biotechnology, contributing to impactful biotech research and publications.